Carfilzomib cyclophosphamide dexamethasone multiple myeloma

13697. 1 is a single arm phase II trial of weekly carfilzomib, cyclophosphamide and dexamethasone (wKCd), exploring a convenient immunomodulator (IMiD)-free regimen in relapsed myeloma

2024-03-29
    Finasteride effects on muscle
  1. in combination with
  2. 2020;105(4):243428
  3. Group 2: 20 multiple myeloma patients without renal impairment
  4. et al
  5. Of carfilzomib dose reductions, the majority (72